National Cancer Institute
A foundational US government research body that funds critical open-source genome atlases, enabling startup innovations in longevity.
First Mentioned
6/6/2026, 5:15:49 AM
Last Updated
6/6/2026, 5:17:54 AM
Research Retrieved
6/6/2026, 5:17:54 AM
Summary
The National Cancer Institute (NCI) is the principal federal agency in the United States for cancer research and training, operating as the oldest and largest institute within the National Institutes of Health (NIH). Established in 1937, the NCI coordinates the National Cancer Program, conducting and funding extensive research into cancer prevention, diagnosis, and treatment. In recent discussions, such as those highlighted by David Friedberg, the NCI's robust data has been instrumental in linking epigenetic changes and environmental factors—such as exposure to the pesticide Picloram—to rising rates of young-onset colorectal cancer.
Referenced in 1 Document
Research Data
Extracted Attributes
Founded
1937-08-05
Department
U.S. Department of Health and Human Services
Core Mission
Coordinates the United States National Cancer Program, conducting and supporting cancer research, training, and health information dissemination.
Headquarters
Bethesda, Maryland, United States
Annual Budget
$6.9 billion (2020)
Parent Organization
National Institutes of Health (NIH)
Timeline
- The National Cancer Institute Act is signed into law, establishing the NCI as the federal government's principal agency for cancer research and training. (Source: NIH Almanac)
1937-08-05
- House Joint Resolution 468 is passed, dedicating the month of April each year to a voluntary national program for cancer control. (Source: NIH Almanac)
1938-03-28
- A Bureau-level organization is established for NCI, elevating its organizational status under the National Cancer Act of 1971. (Source: NIH Almanac)
1972-07-27
- NCI Director Dr. Frank J. Rauscher, Jr. announces the recognition of the first eight Comprehensive Cancer Centers. (Source: NIH Almanac)
1973-06-20
- NCI makes its first cancer control awards to state health departments to screen low-income women for cervical cancer. (Source: NIH Almanac)
1974-09-12
- NCI researchers report that the molecularly targeted drug bevacizumab slowed tumor growth in patients with metastatic renal cell carcinoma. (Source: NIH Almanac)
2002-05-19
- NCI scientists use microarray technology to predict chemotherapy success in patients with non-Hodgkin lymphoma. (Source: NIH Almanac)
2002-06-19
Wikipedia
View on WikipediaNational Cancer Institute
The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship. NCI is the oldest and has the largest budget and research program of the 27 institutes and centers of the NIH ($6.9 billion in 2020). It fulfills the majority of its mission via an extramural program that provides grants for cancer research. Additionally, the National Cancer Institute has intramural research programs in Bethesda, Maryland, and at the Frederick National Laboratory for Cancer Research at Fort Detrick in Frederick, Maryland. The NCI receives more than US$5 billion in funding each year. The NCI supports a nationwide network of 73 NCI-designated Cancer Centers with a dedicated focus on cancer research and treatment and maintains the National Clinical Trials Network.
Web Search Results
- National Cancer Institute (NCI) - The National Cancer Institute, part of the National Institutes of Health, is the lead federal agency for cancer research
with patient-reported experiences, this approach offers a practical, scalable way to monitor symptoms and inform more targeted care. [Likes: 13, Comments: 1]; National Cancer Institute (NCI) (1w): This National Brain Tumor Awareness Month, we're highlighting NCI-CONNECT—an NCI program focused on advancing understanding of rare brain and spine tumors through collaboration. By connecting patients, providers, researchers, and advocates, NCI-CONNECT is helping overcome the challenges of rare cancers—where expertise, data, and access are often limited. Through national and global partnerships, the program is accelerating research, expanding clinical trial opportunities, and working toward better outcomes for people facing these complex diseases. Learn more. [Likes: 45, Comments: 2]; National [...] every breakthrough, there is a nurse ensuring patients are informed, supported, and heard. As we look ahead—to advances in immunotherapy, functional precision medicine, and faster clinical trials—the role of oncology nurses is only becoming more essential to delivering innovation at scale . They are not just part of the system—they are what makes the system work. [Likes: 27, Comments: 2]; National Cancer Institute (NCI) (1w): Sleep is a critical part of cancer care—and for many brain tumor patients, it’s a daily challenge. This Brain Tumor Awareness Month, we’re sharing how NCI researchers are using wearable technology to better understand sleep patterns and improve patient outcomes. By combining real-time data from devices with patient-reported experiences, this approach offers a [...] an important step forward not only for children with these devastating cancers, but also for the broader future of CAR T-cell therapies in solid tumors. Read more about the study and ongoing research efforts: [Likes: 47, Comments: 2]; National Cancer Institute (NCI) (6d): Oncology nurses are essential members of cancer care teams, providing compassionate care for many patients navigating the complexities of cancer treatment. However, cancer care team members, including oncology nurses, face administrative burdens from poorly integrated electronic health record systems and suboptimal prior authorization processes that undermine patient care. These administrative tasks, which can consume significant time and resources, often pull oncology nurses away from their most important job—providing
- National Cancer Institute (NCI) | National Institutes of Health (NIH)
August 5, 1937—The National Cancer Institute Act establishes the National Cancer Institute as the federal government’s principal agency for conducting research and training on the cause, diagnosis, and treatment of cancer. The bill also calls upon NCI to assist and promote similar research at other public and private institutions. An appropriation of $700,000 for each fiscal year is authorized. (P.L. 75-244) March 28, 1938—House Joint Resolution 468, 75th Congress, was passed, "To dedicate the month of April in each year to a voluntary national program for the control of cancer." [...] May 19, 2002—Researchers from NCI reported that the molecularly targeted drug bevacizumab slowed tumor growth in patients with metastatic renal cell carcinoma, the most common form of kidney cancer in adults. June 19, 2002—NCI scientists used microarray technology to determine the patterns of genes that are active in tumor cells from which they could predict whether patients with the most common form of non-Hodgkin lymphoma in adults are likely to be cured by chemotherapy. [...] July 27, 1972—A Bureau-level organization was established for NCI, giving the Institute and its components organizational status commensurate with the responsibilities bestowed on it by the National Cancer Act of 1971. June 20, 1973—NCI director Dr. Frank J. Rauscher, Jr., announced that eight institutions were recognized as Comprehensive Cancer Centers to bring results of research as rapidly as possible to a maximum number of people. (In 2017, there are 69 NCI designated cancer centers.) September 12, 1974—NCI made its first cancer control awards to state health departments for a three-year program to screen low-income women for cancer of the uterine cervix. At its peak in 1978, the program had grown to a total of 32 states and territories.
- National Cancer Institute - Wikipedia
Edit this at Wikidata The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship. [...] | Institutes | National Cancer Institute National Eye Institute National Heart, Lung, and Blood Institute National Human Genome Research Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute of Child Health and Human Development National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute on Drug Abuse National Institute of Environmental Health Sciences National Institute of General Medical Sciences [...] using the hollow fiber assay. The third phase of the study is the human tumor xenograft evaluation.
- National Cancer Institute (NCI) | NIH Intramural Research Program
Clinical Director: Sharon A. Savage, M.D. The Division of Cancer Epidemiology and Genetics (DCEG) is a global leader in cancer epidemiology and genetics research. With its cadre of renowned epidemiologists, geneticists, and biostatisticians, DCEG conducts population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The Division’s research portfolio informs biological concepts, clinical practice, and public health policy. DCEG is uniquely positioned to conduct epidemiologic research projects that are high risk in nature and may require long-term commitments of scientific staff and resources, a coordinated national programmatic approach, or a rapid response to emerging scientific issues. [...] ## Division of Cancer Epidemiology and Genetics (DCEG) Scientific Director: Stephen J. Chanock, M.D. Clinical Director: Sharon A. Savage, M.D. [...] NIH Intramural Research Program, Our Research Changes Lives ## Navigation controls ## Social follow links ## Main navigation # National Cancer Institute (NCI) ## Center for Cancer Research (CCR) Director: Anthony Letai, M.D., Ph.D. Clinical Director: James L. Gulley, M.D., Ph.D. Scientific Director for Clinical Research: Deborah E. Citrin, M.D. The Center for Cancer Research (CCR) was established to inform and empower the entire cancer research community by making breakthrough discoveries in basic and clinical cancer research and by developing them into novel therapeutic interventions for adults and children afflicted with cancer or infected with HIV. CCR works toward this goal by: Learn more about the National Cancer Institute’s Center for Cancer Research.
- The National Cancer Institute's Center For Cancer Research | Center for Cancer Research
National Cancer Institute - Cancer.gov The National Cancer Institute's # Center for Cancer Research Creating the cancer medicines of tomorrow through bold biomedical research Learn More ## Latest News This image shows how genetic differences linked to African ancestry (gold DNA strand, left) and Caucasian ancestry (blue DNA strand, right) may affect how genes are controlled in prostate cancer. The glowing dots represent genetic differences in the DNA, while the connections to the center network represent artificial intelligence helping researchers identify important DNA changes and their biological effects. May. 27, 2026
Wikidata
View on WikidataInstance Of
DBPedia
View on DBPediaLocation Data
Istituto Nazionale dei Tumori, Piazzale Paolo Gorini, Città Studi, Municipio 3, Milano, Rodano, Milano, Lombardia, 20133, Italia
Coordinates: 45.4750000, 9.2313680
Open Map